Meta-Analysis
Copyright ©The Author(s) 2021.
World J Hepatol. Sep 27, 2021; 13(9): 1190-1202
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1190
Figure 1
Figure 1 PRISMA flow chart of the included studies.
Figure 2
Figure 2 Global seroprevalence of hepatitis B virus serological markers among healthcare workers. CI: Confidence interval; HBV: Hepatitis B virus.
Figure 3
Figure 3 Global seroprevalence of hepatitis B serological markers among healthcare workers.

  • Citation: Mahamat G, Kenmoe S, Akazong EW, Ebogo-Belobo JT, Mbaga DS, Bowo-Ngandji A, Foe-Essomba JR, Amougou-Atsama M, Monamele CG, Mbongue Mikangue CA, Kame-Ngasse GI, Magoudjou-Pekam JN, Zemnou-Tepap C, Meta-Djomsi D, Maïdadi-Foudi M, Touangnou-Chamda SA, Daha-Tchoffo AG, Selly-Ngaloumo AA, Nayang-Mundo RA, Yéngué JF, Taya-Fokou JB, Fokou LKM, Kenfack-Momo R, Tchami Ngongang D, Atembeh Noura E, Tazokong HR, Demeni Emoh CP, Kengne-Ndé C, Bigna JJ, Boyomo O, Njouom R. Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis. World J Hepatol 2021; 13(9): 1190-1202
  • URL: https://www.wjgnet.com/1948-5182/full/v13/i9/1190.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v13.i9.1190